vs
BRANDYWINE REALTY TRUST（BDN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
BRANDYWINE REALTY TRUST的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$127.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 4.5%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 0.7%）
白兰地房地产信托是一家总部位于费城的房地产投资信托基金（REIT），核心投资方向为费城、华盛顿特区以及德克萨斯州奥斯汀的写字楼物业，是美国聚焦核心都市商务地产的专业REIT运营商。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BDN vs PBYI — 直观对比
营收规模更大
BDN
是对方的1.7倍
$75.5M
营收增速更快
PBYI
高出23.2%
4.5%
两年增速更快
PBYI
近两年复合增速
0.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $127.0M | $75.5M |
| 净利润 | $-48.8M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 1.2% | 22.7% |
| 净利率 | -38.4% | — |
| 营收同比 | 4.5% | 27.7% |
| 净利润同比 | -80.4% | — |
| 每股收益（稀释后） | $-0.28 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BDNPBYI
| Q1 26 | $127.0M | — | ||
| Q4 25 | $121.0M | $75.5M | ||
| Q3 25 | $121.4M | $54.5M | ||
| Q2 25 | $120.6M | $52.4M | ||
| Q1 25 | $121.5M | $46.0M | ||
| Q4 24 | $121.9M | $59.1M | ||
| Q3 24 | $131.8M | $80.5M | ||
| Q2 24 | $125.3M | $47.1M |
净利润BDNPBYI
| Q1 26 | $-48.8M | — | ||
| Q4 25 | $-36.7M | — | ||
| Q3 25 | $-25.9M | $8.8M | ||
| Q2 25 | $-88.7M | $5.9M | ||
| Q1 25 | $-27.0M | $3.0M | ||
| Q4 24 | $-44.5M | — | ||
| Q3 24 | $-165.2M | $20.3M | ||
| Q2 24 | $30.2M | $-4.5M |
毛利率BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 61.3% | 69.3% | ||
| Q3 25 | 62.6% | 77.7% | ||
| Q2 25 | 62.4% | 76.5% | ||
| Q1 25 | 60.8% | 77.1% | ||
| Q4 24 | 61.2% | 76.4% | ||
| Q3 24 | 64.9% | 63.9% | ||
| Q2 24 | 63.1% | 77.4% |
营业利润率BDNPBYI
| Q1 26 | 1.2% | — | ||
| Q4 25 | 22.8% | 22.7% | ||
| Q3 25 | 20.8% | 17.6% | ||
| Q2 25 | -34.3% | 12.7% | ||
| Q1 25 | 12.5% | 8.7% | ||
| Q4 24 | 18.0% | 22.6% | ||
| Q3 24 | -7.2% | 27.4% | ||
| Q2 24 | 15.5% | -4.6% |
净利率BDNPBYI
| Q1 26 | -38.4% | — | ||
| Q4 25 | -30.3% | — | ||
| Q3 25 | -21.3% | 16.2% | ||
| Q2 25 | -73.5% | 11.2% | ||
| Q1 25 | -22.2% | 6.5% | ||
| Q4 24 | -36.5% | — | ||
| Q3 24 | -125.4% | 25.2% | ||
| Q2 24 | 24.1% | -9.6% |
每股收益（稀释后）BDNPBYI
| Q1 26 | $-0.28 | — | ||
| Q4 25 | $-0.21 | $0.26 | ||
| Q3 25 | $-0.15 | $0.17 | ||
| Q2 25 | $-0.51 | $0.12 | ||
| Q1 25 | $-0.16 | $0.06 | ||
| Q4 24 | $-0.25 | $0.40 | ||
| Q3 24 | $-0.96 | $0.41 | ||
| Q2 24 | $0.17 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | — | $130.3M |
| 总资产 | $3.6B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BDNPBYI
| Q1 26 | $36.2M | — | ||
| Q4 25 | $32.3M | $97.5M | ||
| Q3 25 | $75.5M | $94.4M | ||
| Q2 25 | $122.6M | $96.0M | ||
| Q1 25 | $29.4M | $93.2M | ||
| Q4 24 | $90.2M | $101.0M | ||
| Q3 24 | $36.5M | $96.7M | ||
| Q2 24 | $30.4M | $96.8M |
总债务BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $22.7M | ||
| Q3 25 | $2.3B | $34.0M | ||
| Q2 25 | $2.3B | $45.3M | ||
| Q1 25 | $2.2B | $56.7M | ||
| Q4 24 | $2.2B | $68.0M | ||
| Q3 24 | $2.3B | $79.3M | ||
| Q2 24 | $2.2B | $90.7M |
股东权益BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $792.7M | $130.3M | ||
| Q3 25 | $841.5M | $115.3M | ||
| Q2 25 | $879.8M | $104.7M | ||
| Q1 25 | $993.6M | $97.1M | ||
| Q4 24 | $1.0B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $1.3B | $48.5M |
总资产BDNPBYI
| Q1 26 | $3.6B | — | ||
| Q4 25 | $3.6B | $216.3M | ||
| Q3 25 | $3.3B | $202.9M | ||
| Q2 25 | $3.4B | $194.9M | ||
| Q1 25 | $3.4B | $196.2M | ||
| Q4 24 | $3.5B | $213.3M | ||
| Q3 24 | $3.6B | $220.7M | ||
| Q2 24 | $3.8B | $205.0M |
负债/权益比BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 3.23× | 0.17× | ||
| Q3 25 | 2.70× | 0.30× | ||
| Q2 25 | 2.63× | 0.43× | ||
| Q1 25 | 2.23× | 0.58× | ||
| Q4 24 | 2.13× | 0.74× | ||
| Q3 24 | 2.06× | 1.12× | ||
| Q2 24 | 1.73× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $116.7M | $14.4M | ||
| Q3 25 | $47.5M | $9.7M | ||
| Q2 25 | $34.4M | $14.1M | ||
| Q1 25 | $6.3M | $3.6M | ||
| Q4 24 | $181.1M | $15.6M | ||
| Q3 24 | $52.2M | $11.0M | ||
| Q2 24 | $48.2M | $1.0M |
自由现金流BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率BDNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 1.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BDN
| Rents | $120.7M | 95% |
| Third party management fees, labor reimbursement and leasing | $4.7M | 4% |
PBYI
暂无分部数据
